Proof
Real World Evidence.
Revenue Infrastructure is not a theoretical framework. It is a system with measurable outcomes. The evidence below represents results from BioAlliance client engagements tracked across multiple years. Every number is drawn from documented engagement data.
Engagement Results
Documented Outcomes, Not Projections.
Five tracked client engagements over a five year period.
In Their Words
Client Testimonials.
BioAlliance has been a consistent and trusted commercial partner for GLSA. The newsletter program they built for us has become one of our most effective tools for staying visible and relevant across our network. Jim understands the life sciences commercial environment at a level that most consultants simply do not.
Denise McNerney and Chris MatheusGLSA
Trusted By
Client Organizations.
Your Turn
Every Engagement Starts With A Diagnostic.
The score sets the baseline. The specification sets the plan. The build follows it.
Real World Evidence.
Stat Grid, 8 Numbers
Global CRO. Six Years Of Revenue Infrastructure Deployment.
Over a six-year engagement, BioAlliance designed and operated the full Revenue Infrastructure system for a global contract research organization. The engagement included a newsletter program, a quarterly webinar series, and market intelligence support across multiple therapeutic areas and geographic markets.
More than 5 million market touches generated across all channels.
Subscriber database grown from approximately 3,000 to more than 6,000 qualified industry contacts.
Engagement sustained for six consecutive years.
Commercial Outcome
The newsletter became the organization’s most consistent commercial visibility tool across the engagement period. Prospects who had never spoken to the BD team knew the organization’s name, positioning, and market perspective before a first conversation began. BD team reported materially warmer first conversations at year three compared to year one.
Five Clients. Five Years. Documented Commercial Outcomes.
Across five client engagements tracked over a five-year period, BioAlliance measured commercial performance improvements against pre-engagement baselines across five key metrics.
Measured across five client engagements over five years.
Organizations that remained in the system for 24 months or more consistently outperformed those that exited after 12 months or fewer. The compounding effect of sustained infrastructure operation is the primary driver of the improvement differential.
Documented Results
+50%, Increase in prospecting activity +125%, Growth in qualified leads +200%, More discovery and qualification meetings +250%, More proposals and RFP responses submitted +400%, Improvement in closed deals
Testimonials.
Testimonial 1, Denise McNerney and Chris Matheus, GLSA
BioAlliance has been a consistent and trusted commercial partner for GLSA. The newsletter program they built for us has become one of our most effective tools for staying visible and relevant across our network. Jim understands the life sciences commercial environment at a level that most consultants simply do not.
Testimonial 2, Hillary Veeder, Cobble Consulting
Working with BioAlliance changed how I think about commercial infrastructure. The diagnostic was direct and specific in a way I had not experienced from any other advisor. The recommendations were actionable immediately.
Testimonial 3, Graeme Ladds, PharSafer
Jim Sarene brings a level of commercial intelligence to life sciences organizations that is rare. The Signal Suite intelligence he delivers gives our team a genuine competitive advantage in identifying sponsor opportunities before the market does.